secwatch.observer — SEC 8-K summary
======================================

Issuer:     XWELL, Inc. (XWEL)
CIK:        0001410428
Form:       8-K
Filed at:   2024-04-16T23:59:59+00:00
Accession:  0001104659-24-047806
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XWELL reports FY2023 revenue drop to $30.1M, net loss $28.0M; restates Q3 2023 results
--------------------------------------------------------------------------------

- FY2023 total revenue $30.1M (down 46% from $55.9M in 2022); operating loss $28.2M, net loss $28.0M.
- Non-cash impairment charges of $8.9M; restated Q3 2023 to correct $1.6M understatement of Treat segment impairment.
- XpresSpa revenue grew 39% YoY to $19.5M; plans for Penn Station location and Naples Wax Center expansion to ~10 locations by early 2025.
- CDC biosurveillance program expanded to $36.7M funding; new collection sites at MIA and ORD.
- Cash and marketable securities totaled $23.0M at Dec 31, 2023; no long-term debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1410428/000110465924047806/0001104659-24-047806-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1410428/000110465924047806/tm2411854d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-047806

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer